Investigational drug · Phase 3
TMP
Also called: SMX, Trimethoprim-sulfamethoxazole
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Urinary Tract Infections, Candidemia, Mycoses.
Phase 3Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
282
Any phase or sponsor naming "TMP"
First trial start
2020
May 11, 2020
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TMP", any sponsor or status.
Conditions studied
As listed on its trial records.
- Urinary Tract Infections
- Candidemia
- Mycoses
- Fungal Infection
- Fungemia
- Invasive Candidiasis
- Pneumocystis
- Mold Infection
- Invasive Fungal Disease
- Prophylaxis of Invasive Fungal Infections
Approved drugs for the same conditions: Urinary tract infection · Fungal infections · Infectious disease and vaccines · Kidney and urology
Largest trials
Live from ClinicalTrials.gov: studies naming "TMP" as an intervention, largest first.
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
NCT03535558 · 239,306 participants · Start May 17, 2018 · Primary completion Dec 31, 2018
Drug: Fluoroquinolone (FQ); Azithromycin (AZ) and 1 more · For: Bronchitis; Sinusitis; Urinary Tract Infections
Sites: Titusville, New Jersey
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
NCT03479736 · 117,911 participants · Start Nov 20, 2017 · Primary completion May 21, 2018
Drug: Oral Fluoroquinolones (FQ); Other Antibiotics · For: Retinal Detachment; Achilles Tendon; Aneurysm, Dissecting
Sites: Titusville, New Jersey
- Etiology, Prevention and Treatment of Neonatal Infections in the CommunityPivotal-lookingCompleted
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
NCT00198627 · 16,359 participants · Start Dec 2003 · Primary completion Sep 2007
Drug: Co-Trimoxazole; TMP-SMZ · For: Bacterial Infection; Infectious Disease
Sites: Dhaka, Bangladesh
- Study to Improve Survival Among HIV-Exposed Infants in BotswanaPivotal-lookingCompleted
Harvard School of Public Health (HSPH)Academic, hospital or other
NCT01229761 · 3,724 participants (planned) · Start May 2011 · Primary completion Mar 2015
Drug: cotrimoxazole prophylaxis; cotrimoxazole placebo · For: HIV Infections; Neutropenia; Anemia
Sites: Gaborone, Botswana; Lobatse, Botswana; Molepolole, Botswana
- Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/SulfamethoxazolePivotal-lookingStatus unknown
Umeå UniversityAcademic, hospital or other
NCT02734732 · 2,800 participants (planned) · Start Apr 2015 · Primary completion Apr 2020
Drug: Trimethoprim/Sulfamethoxazole; Ciprofloxacin · For: Prostate Infection
Sites: Östersund, Sweden; Sundsvall, Sweden; Ängelholm, Sweden · 5 sites in all
- A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected PatientsPivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00000748 · 2,500 participants
Drug: Sulfamethoxazole-Trimethoprim · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: San Francisco, California; Stanford, California; Denver, Colorado · 24 sites in all
- Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"Pivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00729937 · 2,265 participants · Start Apr 2009 · Primary completion May 2013
Drug: Cephalexin; Clindamycin and 1 more · For: Staphylococcal Infection
Sites: Phoenix, Arizona; Sylmar, California; Baltimore, Maryland · 5 sites in all
- ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe PneumoniaPivotal-lookingCompleted
King George's Medical UniversityAcademic, hospital or other
NCT00396526 · 2,000 participants · Start Apr 2004
Drug: Oral Co-trimoxazole (8mg/kg/day trimithoprim) twice a day for five days vs. oral amoxycillin (20 mg/kg/day) thrice a day for three days. · For: Non-Severe Pneumonia; Under-Fives; Children
Sites: Lucknow, India
- Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and WarfarinPivotal-lookingTerminated
University of PennsylvaniaAcademic, hospital or other
NCT00870298 · 1,971 participants · Start Aug 2006 · Primary completion Jan 2007
Drug: Trimethoprim/Sulfamethoxazole and Warfarin · For: Prescribers' Drug Orders
- Cotrimoxazole Prophylaxis in Severely Malnourished ChildrenPivotal-lookingCompleted
University of OxfordAcademic, hospital or other
NCT00934492 · 1,781 participants · Start Nov 2009 · Primary completion Apr 2014
Drug: Cotrimoxazole dispersible tablet; Placebo dispersible tablet · For: Nutrition Disorders; Life-threatening Infection
Sites: Kilifi, Kenya; Malindi, Kenya; Mombasa, Kenya · 4 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Exposure-informed deconstruction of Chaihu Shugan San links tetramethylpyrazine-paeoniflorin to PRKACA-related neurotrophic signaling and brain-gut pharmacology.
Zhou R, Cai Z, Wang Y, et al. · J Ethnopharmacol 2027
- Coupling adsorbate evolution and lattice oxygen mechanisms via FeOCo/V interfacial bonds in δ-FeOOH/CoVP-B for durable alkaline oxygen evolution.
Su Q, Zhao Z, Long P, et al. · J Colloid Interface Sci 2027
- Design of highly stable and scalable three-dimensional alginate-encapsulated cobalt(III) oxide-graphitic carbon nitride-bismuth(III) oxide beads for peroxymonosulfate photoactivation toward antibiotic oxidation in a real water matrix.
Zouggari H, Mahir FZ, Diez AM, et al. · J Colloid Interface Sci 2027
- Reversible Sequestration and Release of GFP-Tagged Proteins in Mammalian Cells Using Small-Molecule-Responsive Synthetic Condensates.
Fukaya Y, Tsukiji S · Methods Mol Biol 2027
- Nocardia terpenica bacteremia confirmed by blood culture in a patient with granulocytopenia and Aspergillus fumigatus coinfection: a first case report.
He X, Zhou J, Long S, et al. · Diagn Microbiol Infect Dis 2027
- Mechanistic insights into ultrafiltration fouling mitigation by coagulation pretreatment in livestock biogas slurry treatment.
Xie W, Luo A, Tang P, et al. · Waste Manag 2027
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.